Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
06/1998
06/09/1998US5763406 Method for the treatment of conditions caused by herpes virus infections
06/09/1998US5763404 Methods for using LHRH antagonists with low histamine release
06/09/1998US5763397 Glycopeptides, a process for their preparation and their use
06/09/1998US5763393 Ability to bind n-methylasperate receptors; treatment fornervous system disorders
06/09/1998US5763173 Nucleic acid ligand inhibitors to DNA polymerases
06/09/1998US5763164 Immunogenic cancer proteins and peptides and methods of use
06/09/1998US5762906 Further improvements relating to radiolabelling of proteins
06/04/1998WO1998023960A1 Assay method for peptide specific t-cells
06/04/1998WO1998023644A1 Peptide derivatives
06/04/1998WO1998023637A1 Cyclohexapeptides having antimicrobial activity
06/04/1998WO1998023636A1 Heptapeptide oxytocin analogues
06/04/1998WO1998023287A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
06/04/1998WO1998004294A3 Radiolabeled annexins
06/04/1998DE19649266A1 The new peptide lipohexin
06/04/1998CA2272632A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
06/03/1998EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties
06/03/1998EP0845004A1 Epitope tagging system
06/03/1998EP0844882A1 Appetite regulating compositions
06/03/1998CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition
06/03/1998CN1183785A Novel peptides and remedy for bone diseases contg. same as active ingredient
06/03/1998CN1183784A Peptides and remedy for autoimmune diseases comprising same
06/02/1998US5760188 Marker for neurotensin receptor
06/02/1998US5760176 Hydrophobic attachment site for adhesion peptides
06/02/1998US5760003 Hemoregulatory peptides
06/02/1998US5760002 Analgesics
06/02/1998US5760001 Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
06/02/1998US5760000 Administering a polypeptide
06/02/1998US5759996 Reduce bone resorption, angiogenesis, and restenosis
06/02/1998US5759995 Administering cyclomarin a to treat herpes virus infections
06/02/1998US5759994 Antithrombin peptide for cardiovascular disorders
06/02/1998US5759991 Neurotrophic peptide derivatives
06/02/1998US5759808 Immunoglobulins devoid of light chains
06/02/1998US5759792 Antigenic regions of tumour-liberated particles (TLP) complexes and antibodies against the same
06/02/1998US5759551 Luteinizing hormone releasing hormone peptides that prevent growth of the prostate gland
06/02/1998US5759516 Peptide-metal ion pharmaceutical preparation
06/02/1998US5759515 Polyvalent peptide pharmaceutical applications
06/02/1998CA1339897C Peptide boronic acid inhibitors of trypsin-like proteases
05/1998
05/28/1998WO1998022503A2 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies
05/28/1998WO1998022498A1 Cyclic hexapeptides having antibiotic activity
05/28/1998WO1998022497A1 Preprotachykinin-c gene encoding substance z tachykinin precursor
05/28/1998WO1998022496A2 Antiviral peptide derivatives
05/28/1998WO1998022495A2 De-analoques and derivatives of bradykinin 1-5 fragment(bk1-5) and their retropeptides having antikinin activity and uses thereof
05/28/1998WO1998022438A1 Cyclic imines as pesticides
05/28/1998WO1998022125A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
05/28/1998WO1998022122A1 Alkyl peptide amides and applications
05/28/1998DE19648011A1 Cyclische Imine Cyclic imines
05/28/1998CA2272865A1 Alkyl peptide amides and applications
05/28/1998CA2272095A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties
05/28/1998CA2271714A1 Preprotachykinin-c gene encoding substance z tachykinin precursor
05/28/1998CA2271288A1 Antiviral peptide derivatives
05/27/1998EP0844252A2 Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
05/27/1998EP0843516A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/27/1998CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies
05/27/1998CN1183104A Cyclic pentapeptide LH-RH receptor antagonists
05/27/1998CN1183103A Peptide compositions with growth factor-like activity
05/26/1998US5756674 Fusion proteins
05/26/1998US5756465 Protease enzyme inhibitors
05/26/1998US5756452 Cyclic polypeptide
05/26/1998US5756349 Culture of cells and radioimmunoassay
05/26/1998US5756343 Cell stress transcriptional factors
05/26/1998US5756287 Complexing
05/22/1998WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity
05/22/1998WO1998021230A1 Cyclic peptides that bind to urokinase-type plasminogen activator receptor
05/22/1998WO1998021229A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998WO1998020887A1 Polyphosphoinositide binding peptides for intracellular drug delivery
05/22/1998WO1998020885A1 Analogs of peptide yy and uses thereof
05/22/1998WO1998020836A2 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/22/1998CA2271788A1 Analogs of peptide yy and uses thereof
05/22/1998CA2270871A1 Peptide compounds useful for modulating fgf receptor activity
05/22/1998CA2270158A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them
05/22/1998CA2242335A1 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
05/20/1998EP0842946A1 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
05/20/1998EP0842943A2 5-Ring heterocycles as inhibitors of leukocyte adhesion and as VLA-4 antagonists
05/20/1998EP0842269A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof
05/20/1998EP0842196A1 Cell adhesion inhibitors
05/20/1998EP0842195A1 Peptide inhibitors of fibronectine
05/20/1998EP0842192A2 Antimicrobial cationic peptides
05/20/1998EP0842191A2 Cyclosporin derivatives with anti-hiv activity
05/20/1998EP0842190A1 Process for producing dolastatin 15 and intermediates thereof
05/20/1998EP0842142A1 PROCESS FOR PRODUCING $g(a)-(N,N DIALKYL)-AMINO CARBOXYLIC ACID AMIDES
05/20/1998EP0841940A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy
05/20/1998EP0824545A4 Peptide compositions with growth factor-like activity
05/20/1998EP0745091A4 Use of angiotensin ii analogs in tissue repair
05/20/1998EP0597997B1 Lanthionine bridged peptides
05/20/1998EP0463081B1 Hormone response element compositions and assay
05/20/1998EP0463053B1 Production and use of anthelmintic agents and protective immunogens
05/20/1998CN1182436A Thrombin inhibitors based on the amino acid sequence of hirudin
05/20/1998CN1182135A Genetic engineering synthesis method of horseshoe crab extract as anti-fungus polypeptide
05/19/1998US5753788 Photolabile nucleoside protecting groups
05/19/1998US5753628 Peptide inhibitors of TNF containing predominantly D-amino acids
05/19/1998US5753619 Composition for prophylaxis or treatment of pulmonary circulatory diseases
05/19/1998US5753617 Peptide inhibitors of cellular adhesion
05/19/1998US5753615 Neuropeptides and their use as insecticides
05/19/1998US5753450 Bone resorption assay
05/19/1998US5753226 Contacting cells with compound which binds to reovirus type 3 receptor
05/19/1998US5753206 Radiometal-binding analogues of luteinizing hormone releasing hormone
05/19/1998US5753093 Using a linker lipid for attaching a membrane including a plurality of ionophores to an electrode; providing a space between the membrane and the electrode
05/19/1998CA2190679A1 Lymphocyte tachykinin
05/15/1998CA2220784A1 5-membered ring heterocycles as inhibitors of leucocyte adhesion and as vla-4 antagonists
05/14/1998WO1998020036A1 Constrained helical peptides and methods of making same
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 423